Trial
NCT03204539
INdividualized ITI Based on Fviii(ATE) Protection by VWF
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Hemophilia A With Inhibitor
Intervention
Wilate
Why stopped
Termination of funding from sponsor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-29